BRIAN J. DAVIS, District Judge.
Plaintiffs' Second Amended Complaint ("Second Amended Complaint") sets forth four causes of action: (1) negligence; (2) strict liability; (3) fraudulent concealment; and (4) loss of consortium. The gravamen of Plaintiffs' Second Amended Complaint is that Plaintiff, Darryl Dugas was exposed to asbestos fibers which led to his development of malignant mesothelioma. Mr. Dugas' exposure to asbestos came from his contact with asbestos-containing products during his tenure with the United States Navy. The products were either mined, processed, supplied, manufactured, or distributed by Defendants, or their predecessors.
Specifically, Defendant UTC argues that Plaintiffs' Second Amended Complaint fails to allege sufficient facts from which a plausible claim for relief can be ascertained as to all claims. Defendants 3M and Shell focus their Motions to Dismiss on Count Three, arguing that Plaintiffs' factual allegations are inadequate to state a claim for fraudulent concealment.
Preliminarily, the Court considers an argument raised by Honeywell International Incorporated ("Honeywell") as adopted and incorporated in Defendants Shell's and 3M's Motions to Dismiss.
To aid courts in determining whether a law is substantive or procedural, "the Supreme Court developed a two-part test in Hanna."
In this case, the state law, Section 774.205, requires that a plaintiff alleging asbestos exposure include with his complaint, among other things, "a written report and supporting test results constituting prima facie evidence of the exposed person's asbestos-related ... physical impairment meeting the requirements of s.
Indeed, another court in this district, relying on Cohen and Hanna held that a plaintiff's failure to meet the pleading requirements found in Section 774.205 did not doom his case because Section 774.205 conflicted "with the basic notice pleading requirements of Federal Rule of Civil Procedure 7 through 10...." Hughes v. Am. Tripoli, Inc., No. 2:04CV485FTM29DNF, 2006 WL 1529051, at *3 (M.D.Fla. May 30, 2006). The court in Braddock v. Orlando Reg'l Health Care Sys., Inc., 881 F.Supp. 580, 582 (M.D.Fla.1995), came to a similar conclusion when it held that Florida's heightened pleading requirements in medical malpractice cases conflict with, and thus give way to, Federal Rule of Civil Procedure 8 in cases sitting in federal court. The Court finds the reasoning of Braddock, Cohen, and Hughes instructive. Federal Rule of Civil Procedure 8 allows a plaintiff's short and plain statement of the facts which establish the plaintiff's right to relief to suffice. Florida's heightened pleading requirement in asbestos cases prohibits what federal procedural law allows, which creates a conflict between Florida's Section 774.205 and Federal Rule of Civil Procedure 8. Because Florida's pleading requirement in asbestos cases conflicts with established federal procedural law, Florida's heightened standard must yield.
Defendants Shell, UTC, and 3M also contend that Mr. Dugas' negligence count should be dismissed pursuant to Federal Rule of Civil Procedure 12(b)(6) because Mr. Dugas' allegations of negligence against them "are almost identical." (Doc. 145 at 5). To survive a Rule 12(b)(6) motion, a complaint is not required to allege painstakingly specific factual allegations, "but only enough facts to state a claim to relief that is plausible on its face." Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007). "A claim has facial plausibility when the plaintiff pleads factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged." Ashcroft v. Iqbal, 556 U.S. 662, 678, 129 S.Ct. 1937, 173 L.Ed.2d 868 (2009) (citation omitted). However, "[a] pleading that offers labels and conclusions or a formulaic recitation of the elements of a cause of action will not do." Id. (quotation and citation omitted).
Regarding Defendant 3M, Mr. Dugas alleges that 3M knew or should have known that users of its safety masks, like plaintiff, expected the masks to protect against a variety of dangerous airborne particles, like asbestos. Despite 3M's knowledge, 3M failed to properly design, manufacture, and sell its safety masks to protect against asbestos fibers. 3M failed to warn its users of the dangers of asbestos, including that 3M's masks would not provide adequate protection from asbestos. Further, when 3M became aware of the inadequacies of its safety masks for those working with and around asbestos, 3M failed to recall and retrofit its safety masks. As a result of 3M's actions (or lack thereof), Mr. Dugas was exposed to deadly asbestos fibers which caused Mr. Dugas to develop malignant mesothelioma. The disease has caused Mr. Dugas to incur substantial medical bills along with substantial pain and suffering. Accordingly, Mr. Dugas has sufficiently alleged facts upon which he may be entitled to relief under a claim of negligence against 3M.
Regarding Defendants Shell and UTC, Mr. Dugas alleges they were responsible for the mining, processing, supplying, manufacturing, and distribution of asbestos containing aircraft components.
Defendants 3M, Shell, and UTC argue that Mr. Dugas' claim under a theory
Regarding 3M, Plaintiffs charge 3M with the design, manufacture, and distribution of safety masks used by Mr. Dugas while he was in the Navy. The masks were allegedly defective because they failed to adequately protect users, like Mr. Dugas, from certain hazardous airborne particulates, like asbestos. Additionally, 3M allegedly failed to provide adequate warning that the masks would not protect users from asbestos. That defect and the failure to warn led to Mr. Dugas inhaling asbestos fibers which caused Mr. Dugas to develop malignant mesothelioma. These facts are specific as to 3M's relationship to the product at issue, the defect in the product, the lack of accompanying warning, and how that defect caused Mr. Dugas' injury. Accordingly, Mr. Dugas has plead a claim for recovery pursuant to a theory of strict liability with sufficient specificity.
As to Defendants Shell and UTC, Plaintiffs state that Shell and UTC designed aircraft components which contained asbestos. Those components were defective because they contained asbestos fibers, which were released when the products were sanded and cleaned in the course of their intended use. At the time of the asbestos-containing components' manufacture, there existed alternative non-asbestos-containing components which could act as viable substitutes for the asbestos-containing components. The exposure to the released asbestos fibers caused Mr. Dugas to develop mesothelioma. These facts establish (1) the relationship of the products to Defendants, (2) that they were defective in that their normal use resulted in the release of asbestos fibers, which (3) caused Mr. Dugas to develop mesothelioma. Defendants' argument that Mr. Dugas does not state with greater specificity the particular design defect which resulted in the release of asbestos fibers is unavailing. See Egbebike v. Wal-Mart Stores E., LP, No. 3:13-CV-865-J-34MCR, 2014 WL 3053184, at *2 (M.D.Fla. July 7, 2014) (holding that an allegation that a mattress was defective because it "popped, producing a large hole" sufficiently described a defect for purposes of a strict products liability claim). That a specific product released asbestos fibers in the course of its intended use, and without warning according to Mr. Dugas, adequately describes a defect in both the design of the product and in the warning of the hazards associated with the foreseeable use of the product.
Defendants 3M, Shell, UTC, and IMO contend that Mr. Dugas' claims of fraudulent concealment should be dismissed because Mr. Dugas' allegations of fraudulent concealment are stated with insufficient particularity and because Defendants had no duty to disclose the risks of asbestos to Mr. Dugas. Under Florida law, a claim for fraudulent concealment is the same as one for fraudulent misrepresentation. Grills v. Philip Morris USA, Inc., 645 F.Supp.2d 1107, 1119 (M.D.Fla. 2009). A claim for fraudulent misrepresentation
Jones v. Gen. Motors Corp., 24 F.Supp.2d 1335, 1339 (M.D.Fla.1998) (citation omitted); see also Johnson v. Davis, 480 So.2d 625, 627 (Fla.1985).
Because a claim for fraudulent concealment sounds in fraud it must meet Rule 9(b)'s heightened pleading standard by "stat[ing] with particularity the circumstances constituting fraud." U.S. v. All Children's Health System, Inc., No. 8:11-cv-1687, 2013 WL 1651811 at *2 (M.D.Fla. Apr. 16, 2013) (quoting Fed.R.Civ.P. 9(b)). "The particularity requirement of Rule 9(b) is satisfied if the complaint alleges `facts as to time, place, and substance of the defendant's alleged fraud, specifically the details of the defendant's allegedly fraudulent acts, when they occurred, and who engaged in them.'" Id. (quoting Hopper v. Solvay Pharm., Inc., 588 F.3d 1318, 1324 (11th Cir.2009) (quotations omitted)). However, "knowledge ... may be alleged generally." Fed.R.Civ.P. 9(b). "The purpose of Rule 9(b) is to alert defendants to the precise misconduct with which they are charged and protect defendants against spurious charges." U.S. ex rel. Matheny v. Medco Health Solutions, Inc., 671 F.3d 1217, 1222 (11th Cir.2012) (citations and quotation omitted). However, the Eleventh Circuit has cautioned that "a court considering a motion to dismiss for failure to plead fraud with particularity should always be careful to harmonize the directives of Rule 9(b) with the broader policy of notice pleading." Friedlander v. Nims, 755 F.2d 810, 813 (11th Cir.1985).
Mr. Dugas specifically alleges that 3M marketed and sold its safety masks for use with asbestos and asbestos containing products. 3M conducted testing of its masks and, after reviewing the results, knew the masks did not protect against asbestos. Despite this knowledge, 3M failed to inform purchasers and users of the masks that the masks did not shield against asbestos exposure. 3M sought to maintain the popularity of its safety masks by omitting information related to the shortcomings of the masks, thus, inducing purchasers and users to continue buying and using the masks. As a result of 3M's failure to disclose the risks associated with the use of its safety masks with and around asbestos and asbestos containing products, users, like Mr. Dugas, were left with a false sense of security and were exposed to asbestos. This exposure caused Mr. Dugas to develop mesothelioma. Mr. Dugas's allegations state the relevant time period, product, and nature of 3M's concealment. Moreover, Mr. Dugas avers 3M had knowledge of its product's limitations and that 3M's concealment of its product's limitations led to his injury. Accordingly, Mr. Dugas' claim of fraudulent concealment against 3M meets Rule 9(b)'s heightened pleading requirement. See Haskin v. R.J. Reynolds Tobacco Co., 995 F.Supp. 1437, 1439 (M.D.Fla.1998).
Mr. Dugas' claims of fraudulent concealment against UTC, Shell, and IMO fail to achieve the same level of specificity found in his claim against 3M. For example, Mr. Dugas dedicates one separate paragraph for UTC, Shell, and IMO, wherein each paragraph only differs by
Defendants' second argument for dismissal of Mr. Dugas' claim of fraudulent concealment is that they were not required to disclose the dangers of their asbestos containing products (or protective masks) to Mr. Dugas because they were not in privity with Mr. Dugas. The argument follows that if Defendants were not in privity with Mr. Dugas, then Defendants owed no duty of care to Mr. Dugas. Mr. Dugas never directly purchased the products at issue in this case. Instead, the Navy procured the products and Mr. Dugas, being in the Navy's employ, became their ultimate user.
The Southern District of Florida confronted a similar issue in In re Asbestos Litigation, 679 F.Supp. 1096, 1099 (S.D.Fla.1987), wherein the defendant manufacturers asserted that the plaintiff users failed to state a claim for breach of implied warranty because there was no privity between the defendants and the plaintiffs. The court reasoned there was privity between the plaintiff users and the defendant manufacturers because the plaintiffs were foreseeable users of the product, and at the time of the distribution of the product the defendants "possessed superior knowledge as to the dangerous propensities of the products." Id. In this case, Defendants were sophisticated designers, manufactures, and distributors that provided various parts and components to the Navy for use in naval aircraft. By virtue of their positions, Defendants were far better equipped with the knowledge of the dangers of their products. Mr. Dugas, as an aircraft mechanic, was a foreseeable user of Defendants' products, and did not know, and was not in a position to know, of the dangers of Defendants' products. Owing to their relative positions, Defendants owed Mr. Dugas a duty of reasonable care to disclose to Mr. Dugas the dangers of the foreseeable use of their products.
In Plaintiffs' Response, they request leave of the Court to cure any pleading defects. Initially, the Court notes such a request is improper. See Horne v. Winn Dixie Inc., No. 306CV1068J25MCR, 2006 WL 3841798, at *3 (M.D.Fla. Dec. 11, 2006) ("[A]ll requests for relief from, or action by, the Court must be in the form of a motion."); Armington v. Dolgencorp, Inc., No. 3:07-CV-1130-J-JRK, 2009 WL 210723, at *2 (M.D.Fla. Jan. 20, 2009) ("It is not appropriate to seek an order for affirmative relief in a response to a motion.") (citing Fed.R.Civ.P. 7(b)). Even considering Plaintiffs' request to amend, however, the Court still finds amendment inappropriate.
"A plaintiff seeking leave to amend its complaint after the deadline designated in a scheduling order must demonstrate good cause under Fed.R.Civ.P. 16(b)." S. Grouts & Mortars, Inc. v. 3M Co., 575 F.3d 1235, 1241 (11th Cir.2009). The Court's original Case Management and Scheduling Order set December 1, 2014 as the deadline for amendments to the pleadings. (Doc. 104; "CMSO"). The CMSO specifically invited Plaintiffs to remedy any deficiencies by the December 1, 2014 deadline, even though Plaintiffs had already twice amended their original Complaint [Doc. 2]. (Docs. 19 and 113). Is it now April 27, 2015, and Plaintiffs offer no showing of good cause why the Court should grant them leave to amend their Second Amended Complaint. Moreover, the amendment deadline was set in an effort to accommodate Plaintiffs' request for an expedited trial in this matter. Discovery is set to close on April 24, 2015, and the parties' Dispositive and Daubert Motions are due May 1, 2015. Thus, Plaintiffs' request to amend their Second Amended Complaint would necessarily delay resolution of this action, which has been expedited at their request.
Accordingly, after due consideration, it is
1. Defendants' Motions to Dismiss [Docs. 141, 145, 154, and 156] is
2. Plaintiffs' claims of fraudulent concealment against United Technologies Corporation, IMO Industries, and Shell Oil Company are